{"altmetric_id":4893598,"selected_quotes":["#EU approves Talimogene laherparepvec from $AMGN for unresectable #melanoma #TVEC #immunotherapy #oncolytic"],"citation":{"altmetric_jid":"ecancerorg","first_seen_on":"2015-12-18T11:30:13+00:00","issns":[],"journal":"ecancer","last_mentioned_on":1450696194,"links":["http:\/\/ecancer.org\/news\/8419-talimogene-laherparepvec-approved-for-unresectable-melanoma.php?utm_source=twitterfeed&utm_medium=twitter","http:\/\/ecancer.org\/news\/8419-talimogene-laherparepvec-approved-for-unresectable-melanoma.php"],"title":"Talimogene laherparepvec approved for unresectable melanoma","type":"news","uri":"http:\/\/ecancer.org\/news\/8419-talimogene-laherparepvec-approved-for-unresectable-melanoma.php"},"altmetric_score":{"score":2.6,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.6},"context_for_score":{"all":{"total_number_of_other_articles":6803403,"mean":6.1842532809271,"rank":2384980,"this_scored_higher_than_pct":64,"this_scored_higher_than":4397285,"rank_type":"exact","sample_size":6803403,"percentile":64},"similar_age_3m":{"total_number_of_other_articles":291546,"mean":8.7578599392885,"rank":91963,"this_scored_higher_than_pct":67,"this_scored_higher_than":198036,"rank_type":"exact","sample_size":291546,"percentile":67},"this_journal":{"total_number_of_other_articles":10171,"mean":2.9410049164208,"rank":2879,"this_scored_higher_than_pct":70,"this_scored_higher_than":7170,"rank_type":"exact","sample_size":10171,"percentile":70},"similar_age_this_journal_3m":{"total_number_of_other_articles":1,"mean":0,"rank":1,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":1,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":5,"practitioner":1},"users":{"twitter":{"cohorts":{"Members of the public":4,"Practitioners (doctors, other healthcare professionals)":2}}},"geo":{"twitter":{"CL":1,"GB":1}}},"counts":{"total":{"posts_count":6},"twitter":{"unique_users_count":6,"unique_users":["PiescheM","hlthnews","ecancer","EU_CanCon","jttdmd","CancerWallonia"],"posts_count":6}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/PiescheM\/statuses\/677834618398236672","license":"gnip","citation_ids":[4893598],"posted_on":"2015-12-18T12:55:41+00:00","author":{"name":"Matthias Piesche","url":"http:\/\/Gofundme.com\/immunotherapy","image":"https:\/\/pbs.twimg.com\/profile_images\/585519282508980225\/zir5JDT6_normal.jpg","description":"AssProf @ UCM. @DanaFarber\/@HarvardMed Alumnus. Interested in #cancer immunology & new biotechnologies. #Fundraising for cancer #immunotherapy research","id_on_source":"PiescheM","tweeter_id":"1852946341","geo":{"lt":-35.4264,"ln":-71.65542,"country":"CL"},"followers":1751},"tweet_id":"677834618398236672"},{"url":"http:\/\/twitter.com\/hlthnews\/statuses\/678081524911185920","license":"gnip","citation_ids":[4893598],"posted_on":"2015-12-19T05:16:48+00:00","author":{"name":"Hlthnews","image":"https:\/\/pbs.twimg.com\/profile_images\/828610774411063296\/6EetzB7Z_normal.jpg","description":"Your best source for health related news","id_on_source":"hlthnews","tweeter_id":"160870443","geo":{"lt":null,"ln":null},"followers":476},"tweet_id":"678081524911185920"},{"url":"http:\/\/twitter.com\/ecancer\/statuses\/678878867768086528","license":"gnip","citation_ids":[4893598],"posted_on":"2015-12-21T10:05:09+00:00","author":{"name":"ecancer","url":"http:\/\/www.ecancer.org","image":"https:\/\/pbs.twimg.com\/profile_images\/449503716438056960\/SqsDdkL0_normal.png","description":"ecancer is a not for profit, open access, independent medical education platform, committed to improving cancer communication & education.","id_on_source":"ecancer","tweeter_id":"19975787","geo":{"lt":52.16045,"ln":-0.70312,"country":"GB"},"followers":12889},"tweet_id":"678878867768086528"},{"url":"http:\/\/twitter.com\/EU_CanCon\/statuses\/678879453934723072","license":"gnip","rt":["ecancer"],"citation_ids":[4893598],"posted_on":"2015-12-21T10:07:29+00:00","author":{"name":"CanCon","url":"http:\/\/www.cancercontrol.eu","image":"https:\/\/pbs.twimg.com\/profile_images\/603645612131758080\/NQtSTAfk_normal.jpg","description":"The joint action to improve cancer control in Europe. FB: http:\/\/t.co\/u4Ktrfgan6, Instagram: http:\/\/t.co\/GfjnHdaJRa LinkedIn: https:\/\/t.co\/74GEJIAYF3","id_on_source":"EU_CanCon","tweeter_id":"2383766186","geo":{"lt":null,"ln":null},"followers":833},"tweet_id":"678879453934723072"},{"url":"http:\/\/twitter.com\/jttdmd\/statuses\/678879928310337536","license":"gnip","rt":["ecancer"],"citation_ids":[4893598],"posted_on":"2015-12-21T10:09:22+00:00","author":{"name":"Jeff Taylor","url":"http:\/\/nwclinicalresearch.com","image":"https:\/\/pbs.twimg.com\/profile_images\/2208285839\/BlackDiamondrun_normal.jpg","description":"Biotech & Clinical Research Guru.\r\n\r\nBiotech Business Consultant; I have spent over 2 decades dedicated to the biotech and medical device industry.","id_on_source":"jttdmd","tweeter_id":"28616383","geo":{"lt":null,"ln":null},"followers":575},"tweet_id":"678879928310337536"},{"url":"http:\/\/twitter.com\/CancerWallonia\/statuses\/678895162190360576","license":"gnip","rt":["ecancer"],"citation_ids":[4893598],"posted_on":"2015-12-21T11:09:54+00:00","author":{"name":"CancerWallonia","image":"https:\/\/pbs.twimg.com\/profile_images\/623178120615604224\/unGEOij0_normal.jpg","description":"Cancer: from Wallonia to the World, from the World to Wallonia -  Cancer: la Wallonie parle au Monde, le Monde parle \u00e0 la Wallonie","id_on_source":"CancerWallonia","tweeter_id":"2848852120","geo":{"lt":null,"ln":null},"followers":602},"tweet_id":"678895162190360576"}]}}